SCHEMBL19954257

SCHEMBL19954257

CCC(C)NCc1ccc(F)c(C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ MRGPRX4 Q96LA9 2/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ ROCK2 O75116 2/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ MEP1B Q16820 2/20 0.38
▸ RARB P10826 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ RARA P10276 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954153 0.88 MRGPRX4 (0.44) MRGPRX4EPHX2NR1H4PPARAPARP1
SCHEMBL17790220 0.80 MRGPRX4 (0.47) CYP2C19MRGPRX4EPHX2NR1H4PPARA
SCHEMBL11888130 0.77 METAP2 (0.51) MRGPRX4PPARAPARP1ALDH1A1LMNA
SCHEMBL15592319 0.76 AKR1C2 (0.48) CYP2C9MRGPRX4PARP1LMNARARB
SCHEMBL19954154 0.76 NR1H4 (0.49) MRGPRX4EPHX2NR1H4PPARAPARP1
SCHEMBL5398835 0.74 KAT8 (0.51) MRGPRX4PPARAPARP1KDM4ELMNA
SCHEMBL19954264 0.74 PARP1 (0.45) HTTPARP1ROCK2ROCK1LMNA
SCHEMBL10943350 0.73 SIGMAR1 (0.54) CYP2D6CYP2C9CYP2C19HTTALDH1A1
SCHEMBL19091135 0.73 MEP1B (0.68) MRGPRX4NR1H4MEP1B
SCHEMBL14670236 0.72 MRGPRX4 (0.51) MRGPRX4PPARAPARP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914740-B2 Tricyclic pyrido-carboxamide derivatives as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-13 — — US disclosed
Send feedback